SCHEMBL594188

SCHEMBL594188

CC(CO)C(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL594189 1.00
SCHEMBL4259672 1.00
Phosphoric Acid SCHEMBL1758764 0.91 SLC7A5 (0.46)
SCHEMBL28890361 0.85 USP2 (0.57)
SCHEMBL10971625 0.83 USP2 (0.59)
SCHEMBL11855669 0.83 USP2 (0.59)
SCHEMBL4755452 0.80 SLC7A5 (0.50)
Isoleucine SCHEMBL22807324 0.80 SLC7A5 (0.50)
SCHEMBL1236513 0.80 SLC7A5 (0.50)
SCHEMBL1236514 0.80 SLC7A5 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081958-A2 COMPOSITIONS AND METHODS FOR IDENTIFYING MUTATIONS OF GENES OF MULTI-GENE SYSTEMS HAVING IMPROVED FUNCTION THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2020-04-23 WO claimed
US-9101662-B2 Compositions with modulating agents FOAMIX PHARMACEUTICALS LTD. (IL) 2015-08-11 US claimed
US-8795693-B2 Compositions with modulating agents FOAMIX LTD. (IL) 2014-08-05 US claimed
CN-102812038-A Treatments For Gastrointestinal Disorders IRONWOOD PHARMACEUTICALS INC 2012-12-05 CN claimed
EP-2097065-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS Foamix Ltd. (IL) 2009-09-09 EP claimed
WO-2008152444-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS FOAMIX LTD. (US) 2008-12-18 WO claimed
US-20080206159-A1 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions FOAMIX LTD. (IL) 2008-08-28 US claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed
CN-118159298-A Method for producing antibody-linker conjugates 阿拉里斯生物技术股份公司 2024-06-07 CN disclosed
CN-116406302-A Method of transglutaminase conjugation with amino acid based linkers 阿拉里斯生物技术股份公司 2023-07-07 CN disclosed
US-20230151394-A1 BIOLOGIC SYNTHESIS OF DIOLS FROM AMINO ACIDS Taizhou Simplu Technology Co., Ltd. (CN) 2023-05-18 US disclosed
US-20230151394-A1 BIOLOGIC SYNTHESIS OF DIOLS FROM AMINO ACIDS Taizhou Simplu Technology Co., Ltd. (CN) 2023-05-18 US disclosed
US-20230151394-A1 BIOLOGIC SYNTHESIS OF DIOLS FROM AMINO ACIDS Taizhou Simplu Technology Co., Ltd. (CN) 2023-05-18 US disclosed
EP-4127197-A1 BIOLOGIC SYNTHESIS OF DIOLS FROM AMINO ACIDS Taizhou Simplu Technology Co., Ltd. (CN) 2023-02-08 EP disclosed
WO-2001064678-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-07 WO disclosed
WO-2001040262-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-06-07 WO disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US disclosed
EP-0787010-A1 AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-06 EP disclosed
WO-1996012499-A1 AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-05-02 WO disclosed